A randomized double blind placebo and active comparator controlled pilot study of UP446 a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

摘要

BackgroundCurrent use of prescribed or over the counter non-steroidal anti-inflammatory drugs (NSAIDs) for pain and osteoarthritis (OA) have untoward gastrointestinal and cardiovascular related side effects, as a result the need for a safe and effective alternative has become unequivocally crucial.